|
CHD1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22169999999355E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.633300E-04 |
| Normal-vs-Stage2 |
4.808200E-01 |
| Normal-vs-Stage3 |
2.562900E-04 |
| Normal-vs-Stage4 |
2.018300E-03 |
| Stage1-vs-Stage2 |
1.296760E-01 |
| Stage1-vs-Stage3 |
4.737200E-01 |
| Stage1-vs-Stage4 |
1.804820E-01 |
| Stage2-vs-Stage3 |
6.044400E-02 |
| Stage2-vs-Stage4 |
3.769600E-02 |
| Stage3-vs-Stage4 |
3.918800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58210000000825E-06 |
| Normal-vs-AfricanAmerican |
3.641900E-03 |
| Normal-vs-Asian |
1.067690E-02 |
| Caucasian-vs-AfricanAmerican |
2.366200E-01 |
| Caucasian-vs-Asian |
9.319800E-01 |
| AfricanAmerican-vs-Asian |
3.087800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.217300E-04 |
| Normal-vs-Female |
9.61830000000274E-05 |
| Male-vs-Female |
6.115200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.753200E-04 |
| Normal-vs-Age(41-60Yrs) |
7.082500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.593690E-04 |
| Normal-vs-Age(81-100Yrs) |
1.401170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.561200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.297600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.486200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.543900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.424400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.587200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.498000E-01 |
| Classical-VS-Follicular |
2.36970000289105E-08 |
| Classical-VS-Other |
3.469200E-01 |
| Classical-VS-Normal |
1.99140000045617E-08 |
| Tall-VS-Follicular |
6.843100E-03 |
| Tall-VS-Other |
5.358200E-01 |
| Tall-VS-Normal |
1.148490E-02 |
| Follicular-VS-Other |
3.860600E-01 |
| Follicular-VS-Normal |
4.921800E-01 |
| Other-VS-Normal |
5.596400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.372000E-02 |
| Normal-vs-N1 |
5.782100E-03 |
| N0-vs-N1 |
6.253600E-02 |
|
|
